AUCD Testimony at FDA Neurological Devices Panel
April 24, 2014
|
| Download |
|
|
AUCD Director of Public Policy Kim Musheno testified at the Food and Drug Administration's Neurological Devices Panel Meeting, expressing AUCD's opposition to the use of electric shock devices and other aversive techniques. Read her testimony at right.
